Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anthracycline Antibiotics
- Molecular classification
- Cytotoxic Antibiotic, Antitumor Agent, DNA Intercalator, Topoisomerase II Inhibitor, Reactive Oxygen Species (ROS) Generator
01
Overview
Anthracycline antibiotics are a class of cytotoxic agents derived from Streptomyces bacteria, used primarily in cancer chemotherapy. They exert their effects through DNA intercalation, topoisomerase II inhibition, and the generation of reactive oxygen species, leading to cell death. While highly effective against many cancers, their use is limited by significant side effects, particularly cardiotoxicity.
- Other names
- Anthracyclines
02
Mechanism of action
DNA intercalation; Topoisomerase II inhibition; Generation of reactive oxygen species (ROS); Chromatin Disruption
03
Biological functions
DNA Replication InhibitionTranscription InhibitionCell Cycle ArrestApoptosis InductionROS-mediated Cellular Damage
04
Disease associations
Cancer
05
Safety considerations
Cardiotoxicity (dose-limiting)Myelosuppression (e.g., neutropenia)Gastrointestinal symptoms (nausea, vomiting)Secondary malignancies (due to mutagenic potential)
06
Interacting drugs
Doxorubicin
4 more in the full profile.
Beyond the preview
Go deeper on Anthracycline Antibiotics.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anthracycline Antibiotics.